Skip to main content

Table 1 Satisfaction and compliance at the end of 3-months trial of Cefaly®

From: Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study

  N (%)
Satisfaction-intent to continuation  
 Yes 23 (65,7%)
 No 12 (34,3%)
Completed 3 months trial  
 Yes 27 (81,8%)
 No 6 (18,2%)
Back to article page